ATOSSA THERAPEUTICS, INC. Convertible Preferred Stock, Shares Issued upon Conversion
ATOSSA THERAPEUTICS, INC. (ATOS) had Convertible Preferred Stock, Shares Issued upon Conversion of 1.33 thousand shares as of 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Notes › Equity
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2018-03-08
- 2017-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 1.33K shares.
- 2017-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 1.33K shares.
- 2017-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 1.33K shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2017-12-31 | 1.33K shares 10-K · filed 2018-03-08 |
| 2017-09-30 | 1.33K shares 10-Q · filed 2017-11-13 |
| 2017-06-30 | 1.33K shares 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |